We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$64.7B
AUM Growth
+$5.24B
Cap. Flow
+$2.36B
Cap. Flow %
3.65%
Top 10 Hldgs %
20.54%
Holding
3,821
New
235
Increased
1,962
Reduced
1,317
Closed
186

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$40.1M
2
T icon
AT&T
T
+$28M
3
FTXO icon
First Trust Nasdaq Bank ETF
FTXO
+$24.3M
4
TTE icon
TotalEnergies
TTE
+$23.7M
5
WMT icon
Walmart Inc
WMT
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 10.68%
2 Financials 9.21%
3 Healthcare 8.48%
4 Industrials 6.92%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGIO
2976
DELISTED
BlackRock 2022 Global Income Opportunity Trust
BGIO
$315K ﹤0.01%
+35,246
New +$315K
CRBP icon
2977
Corbus Pharmaceuticals
CRBP
$183M
$314K ﹤0.01%
1,385
+765
+123% +$124K
FRO icon
2978
Frontline
FRO
$8.56B
$314K ﹤0.01%
53,930
-7,501
-12% -$39.6K
NAT icon
2979
Nordic American Tanker
NAT
$1.33B
$313K ﹤0.01%
149,913
+97,748
+187% +$225K
NRO
2980
Neuberger Real Estate Securities Income Fund Inc
NRO
$189M
$313K ﹤0.01%
66,426
-6,090
-8% -$29.9K
EPAY
2981
DELISTED
Bottomline Technologies Inc
EPAY
$313K ﹤0.01%
4,311
+212
+5% +$13K
RAVN
2982
DELISTED
Raven Industries Inc
RAVN
$313K ﹤0.01%
6,837
+842
+14% +$35.8K
FSK icon
2983
FS KKR Capital
FSK
$3.37B
$312K ﹤0.01%
11,077
+820
+8% +$25.1K
SCHE icon
2984
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$312K ﹤0.01%
12,137
+897
+8% +$23.2K
ONCE
2985
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$312K ﹤0.01%
5,723
-398
-7% -$27.2K
ANIK icon
2986
Anika Therapeutics
ANIK
$277M
$311K ﹤0.01%
7,380
-278
-4% -$11K
BRC icon
2987
Brady Corp
BRC
$4.54B
$311K ﹤0.01%
7,115
+552
+8% +$21.9K
EAD
2988
Allspring Income Opportunities Fund
EAD
$378M
$311K ﹤0.01%
39,213
+2,985
+8% +$23.8K
FEMB icon
2989
First Trust Emerging Markets Local Currency Bond ETF
FEMB
$367M
$311K ﹤0.01%
8,490
-5,620
-40% -$209K
FISI icon
2990
Financial Institutions
FISI
$814M
$311K ﹤0.01%
9,905
+566
+6% +$18.3K
GMS
2991
DELISTED
GMS Inc
GMS
$311K ﹤0.01%
13,385
+5,405
+68% +$137K
GTO icon
2992
Invesco Total Return Bond ETF
GTO
$2.47B
$311K ﹤0.01%
6,036
-193
-3% -$10K
BBVA icon
2993
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$309K ﹤0.01%
49,064
-2,646
-5% -$17.6K
PATK icon
2994
Patrick Industries
PATK
$2.75B
$309K ﹤0.01%
7,827
+421
+6% +$17.3K
MLCO icon
2995
Melco Resorts & Entertainment
MLCO
$2.12B
$308K ﹤0.01%
14,542
+4,706
+48% +$109K
INSI
2996
DELISTED
Insight Select Income Fund
INSI
$308K ﹤0.01%
16,526
-2,431
-13% -$45.3K
RMR icon
2997
The RMR Group
RMR
$335M
$307K ﹤0.01%
3,305
+271
+9% +$23.8K
BSJN
2998
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
$307K ﹤0.01%
11,689
+600
+5% +$15.7K
CGEN icon
2999
Compugen
CGEN
$221M
$306K ﹤0.01%
79,457
+10,000
+14% +$35K
INAP
3000
DELISTED
Internap Corporation
INAP
$306K ﹤0.01%
24,197
+403
+2% +$4.99K

Similar funds

Raymond James & Associates's Q3 2018 Portfolio in Review

As of Q3 2018, Raymond James & Associates held 3,821 positions worth $64.7B, up 8.8% from $59.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates deployed $2.36B of net new capital in Q3 2018, opening 235 new positions and adding to 1,962 existing holdings. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Sanofi, an estimated $40.1M trimmed.

  • Raymond James & Associates's largest Q3 2018 buy was State Street Communication Services Select Sector SPDR ETF: 365,478 shares worth $17.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2018, an estimated $155M increase.
  • Raymond James & Associates's biggest Q3 2018 reduction was Sanofi, cutting an estimated $40.1M.
  • Raymond James & Associates fully exited Abaxis Inc in Q3 2018, selling an estimated $10.5M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $64.7B portfolio in Q3 2018.
  • Raymond James & Associates opened 235 new positions and closed 186 in Q3 2018.
  • Raymond James & Associates's portfolio value rose 8.8% quarter-over-quarter to $64.7B.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.